Potent activation of SARM1 by NMN analogue VMN underlies vacor neurotoxicity
Laura M. Desrochers,
Michael P. Coleman
Posted 19 Sep 2020
bioRxiv DOI: 10.1101/2020.09.18.304261
Posted 19 Sep 2020
SARM1 is intensively studied for its role in promoting axon degeneration in injury and disease. We identify VMN, a metabolite of the neurotoxin vacor, as a potent SARM1 activator, an action likely to underlie vacor neurotoxicity in humans. This study provides novel tools to study SARM1 regulation, supports drug discovery, further links programmed axon death to human disease and identifies a new model where axons are permanently rescued. ### Competing Interest Statement This work is in part funded by a BBSRC/AstraZeneca Industrial Partnership Award and Q.W. and L.M.D. were employees of AstraZeneca for part of the project.
- Downloaded 637 times
- Download rankings, all-time:
- Site-wide: 42,971
- In neuroscience: 6,062
- Year to date:
- Site-wide: 16,273
- Since beginning of last month:
- Site-wide: 9,722
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!